Cepheid

Cepheid is a leading biotechnology research company committed to revolutionizing healthcare through innovative molecular diagnostics. Cepheid's cutting-edge GeneXpert® systems and Xpert® tests automate intricate manual procedures, offering institutions of all sizes the ability to conduct world-class PCR testing with speed, accuracy, and flexibility. Cepheid's extensive portfolio includes tests for respiratory infections, blood virology, women’s and sexual health, tuberculosis, emerging infectious diseases, healthcare-associated infectious diseases, oncology, and human genetics.

Cepheid delivers actionable results where they are most critical, from central laboratories and hospitals to near-patient settings. With a primary address at 904 Caribbean Drive, Sunnyvale, CA 94089, US, and additional locations including Vira Solelh, Maurens-Scopont, 81470, FR; Aston Court, Kingsmead Business Park, Frederick Place, High Wycombe, Buckinghamshire HP11 1LA, GB; and Röntgenv 2, Solna, 171 54, SE, Cepheid is strategically positioned to serve a global clientele. Cepheid is a part of Danaher, leveraging Danaher’s science and technology leadership to ensure that its solutions remain at the forefront of the industry, reaching and benefiting more people.

As part of Danaher's network of Biotechnology, Diagnostics, and Life Sciences businesses, Cepheid unlocks the transformative potential of science and technology to improve lives worldwide. Cepheid continues to drive advancements in molecular diagnostics, enhancing patient care and outcomes. We invite the company’s management to create a customized and exclusive Cepheid company showcase and product listing on our platform, further highlighting their contributions and capabilities.